Vox Markets Logo

BigBlue Broadband, C4X Discovery and Alan Green on 5 stocks

12:37, 25th June 2019

Vox Media Player

 

DYOR Disclaimer

If you find this podcast useful please give it a rating and review on iTunes by clicking here

Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app


On today's Vox Markets Podcast: BigBlue Broadband, C4X Discovery and Alan Green on 4 stocks

Andrew Walwyn, CEO of Bigblu Broadband (BBB) FOLLOW provides a trading update which has shown continued improvement across all financial and operating metrics.

BigBlu Broadband plc (AIM: BBB), is a leading provider of alternative broadband solutions throughout Europe and Australia. BBB delivers a portfolio of super-fast wireless broadband products for consumers and businesses unserved or underserved by fibre. The Company has a significant target market with 27m customers in Europe with speeds of under 4 Mb, and a further 1m in Australia who have been identified as only suitable for either satellite or fixed wireless broadband. High levels of recurring revenue, increasing economies of scale and Government stimulation of the alternative broadband market in many countries provide a solid foundation for significant organic growth as demand for alternative super-fast broadband services increases around the world.


Dr Craig Fox, Chief Scientific Officer of C4X Discovery (C4XD) FOLLOW discusses their collaboration with PhoreMost to accelerate Parkinson's Disease drug discovery pipeline.

C4X Discovery (C4XD) aims to create the world's most productive drug discovery engine by using cutting-edge technologies and expertise to efficiently deliver best-in-class small-molecule medicines to clinical partners for the benefit of patients. The Company's business model focuses on replenishing big pharma discovery pipelines and driving returns through revenue generating pre-clinical licensing deals. In 2018, C4XD successfully out-licensed a pre-clinical programme in addictive disorders to Indivior in a deal worth up to $294m.

(Interview starts at 10 minutes 15 seconds)


Alan Green CEO of Brand Communications talks about:

Bidstack (BIDS) FOLLOW

Tiziana Life Sciences (TILS) FOLLOW

RA International (RAI) FOLLOW

IMC Exploration (IMCP) FOLLOW

Thomas Cook Group (TCG) FOLLOW

(Interview starts at 31 minutes 48 seconds)

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
Watchlist